The global landscape of availability, accessibility and affordability of essential diagnostics and therapeutics for the management of HER2-positive breast cancer: The ONCOLLEGE-001 survey-Reference-Cited by-同舟云学术

The global landscape of availability, accessibility and affordability of essential diagnostics and therapeutics for the management of HER2-positive breast cancer: The ONCOLLEGE-001 survey

Published:2021-06 Issue: Volume:28 Page:100285
ISSN:2213-5383
Container-title:Journal of Cancer Policy
language:en
Short-container-title:Journal of Cancer Policy

Author:

Trapani D.^ORCID,Lengyel C.G.^ORCID,Habeeb B.S.^ORCID,Altuna S.C.^ORCID,Petrillo A.^ORCID,El Bairi K.^ORCID,Hussain S.,Mazher S.A.,Elfaham E.M.,Curigliano G.^ORCID,Khan S.Z.

Publisher

Elsevier BV

Subject

Health Policy,Oncology

Reference36 articles.

1. Cancer burden in the year 2000. The global picture;Parkin;Eur. J. Cancer,2001

2. Performance of Systems of Cancer Care in OECD Countries: Exploration of the Relation between Resources, Process Quality, Governance and Survival in Patients with Breast, Cervical, Colorectal and Lung Cancers;Stevanovic,2011

3. Global Cancer Observatory;International Agency for Research on Cancer,2020

4. Cancer statistics, 2019;Siegel;CA Cancer J. Clin.,2019

5. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries;Allemani;Lancet,2018

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemic Treatment of Patients With Metastatic Breast Cancer: ASCO Resource–Stratified Guideline;JCO Global Oncology;2024-01

2. Discriminatory Ability and Clinical Utility of the AJCC7 and AJCC8 Staging Systems for Breast Cancer in a Middle-Income Setting;Diagnostics;2023-02-10

3. Intravenous Immunoglobulin G (IVIG) Need Assessment Survey Toward Local Manufacturing of IVIG Using a Mini-Pool Plasma Fractionation Technique;Health Services Insights;2023-01

4. Expanding access to biotherapeutics in low-income and middle-income countries through public health non-exclusive voluntary intellectual property licensing: considerations, requirements, and opportunities;LANCET GLOB HEALTH;2023

5. Expanding access to biotherapeutics in low-income and middle-income countries through public health non-exclusive voluntary intellectual property licensing: considerations, requirements, and opportunities;The Lancet Global Health;2023-01